Table 1 Patient characteristics and renal function
From: Efficacy and safety of sugammadex in patients undergoing renal transplantation
Age (years) | 53 (43–61) |
Height (m) | 166 (158–170) |
Weight (kg) | 59 (51–69.5) |
BMI (kg/m2) | 22 (20–24) |
Sex (F/M) | 63 (63.6%), 36 (36.4%) |
Creatinine (mg/dl) | 5.6 (4.5–7.5) |
BUN (mg/dl) | 30 (24.5–34.5) |
eGFR (ml/min/1.73mm3) | 8 (6–11) |
Dialysis episode (number) | |
None or < 1 month | 53 (53.5%) |
< 12 months | 19 (19.2%) |
≧ 12 months | 27 (27.3%) |
Anesthesia (min) | 425 (382–459.5) |
Surgery (min) | 317 (290–358) |
Rocuronium dose (mg) | 160 (130–185) |
Sugammadex dose (mg) | 200 (200–200) |